Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction

This is an investigator-initiated, prospective, single-centre, non-randomized open label study that evaluates the efficacy and safety of initiating empagliflozin during index hospitalization for acute heart failure regardless of LVEF.